Dr. Jacqueline E. Sherbuk, MD

Dr. Sherbuk practices at Florida Department of Health in Tampa, Florida.

Dr. Sherbuk's NPI, 1629480264, was assigned on June 2, 2014. Dr. Sherbuk graduated from New York University School of Medicine in 2014. Dr. Sherbuk holds Florida license ME145563.

Dr. Sherbuk's primary practice is Florida Department of Health, at 1105 E Kennedy Blvd, Tampa, FL 33602 in Hillsborough County. The practice phone is (813) 559-4344.

Dr. Sherbuk's primary practice is Florida Department of Health in Tampa, Florida. Dr. Sherbuk is also affiliated with Tampa General Hospital. The medical group on file is USF Therapy Services. Dmand AI also links Dr. Sherbuk to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sherbuk practices, 3 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Sherbuk's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Sherbuk is board certified in infectious disease by the American Board of Internal Medicine. Dmand AI has Dr. Sherbuk's licenses on file in 2 states: Florida and Virginia.

CMS data shows 121 Medicare services from Dr. Sherbuk across 3 procedure codes in 2024, for 68 Medicare patients. Medicare paid $10,403 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 68 Medicare patients who saw Dr. Sherbuk in 2024. The largest group is 65 to 74, with 30 patients. 75% of them have high blood pressure, and 72% have high cholesterol. 51% are also on Medicaid. Their average risk score is 3.31, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sherbuk's median patient age at 56, with 30% women.

In 2024, Dr. Sherbuk wrote 83 Medicare Part D claims for 17 patients. 30% of them were for generic drugs. CMS names the drug for 15 of them, across 1 drug with 11 or more claims each, at $59,717 in total drug cost. In 2023, CMS named 44 claims across 3 drugs.

Dr. Sherbuk accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 19 papers to Dr. Sherbuk, published from 2014 to 2025. 2018 was the busiest year, with 3. The most frequent topics are Hepatitis C, Bolivia and Chagas Cardiomyopathy. Dr. Sherbuk has published most often in BMJ Case Rep. Dr. Sherbuk's most frequent co-authors are Kathleen A. McManus, MD, Tabor E. Flickinger, MD and Emi Okamoto.

CMS Open Payments shows 2 general payments to Dr. Sherbuk from 2 drug and device companies from 2023 to 2025. Consulting fees make up the largest share, 52% of the total. ADMA BioManufacturing LLC paid the most, $118.

Dr. Sherbuk graduated from New York University School of Medicine in 2014.

Dr. Sherbuk is in network with 11 carriers, including Blue Cross Blue Shield of Michigan, Cigna and United Healthcare. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.